BioMarin Pharmaceutical Inc
BMRN· Nasdaq
Released Aug 3, 2022, after the close
10-Q filed Aug 4, 2022, 35 days after period end · 0001048477-22-000027
| Metric | Q2 2022 | Q2 2021 | Q2 2020 | Q2 2019 |
|---|---|---|---|---|
| Revenue | $533.80M | $501.69M | $429.49M | $387.76M |
| Net Income | $27.66M | $12.94M | -$29.18M | -$37.44M |
| EPS Diluted |
BioMarin Pharmaceutical Inc · CIK 1048477 · Engraved from SEC EDGAR
| $0.15 |
| $0.07 |
| -$0.16 |
| -$0.21 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.